Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes-Reference-Cited by-同舟云学术

Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes

Published:2022-02 Issue: Volume:Volume 14 Page:729-738
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Ten Eyck Jennifer E^ORCID,Kahlon Navkirat,Masih Sonia,Hamouda Danae M,Petros Firas G^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference13 articles.

1. NCCN. NCCN clinical practice guidelines in oncology (NCCN guidelines) for bladder cancer; 2021. Available from: https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed July 27, 2021.

2. PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients

3. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

4. Multidrug resistance in cancer: role of ATP–dependent transporters

5. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occult urothelial carcinoma with mediastinal metastasis: A case report;Oncology Letters;2024-02-09

2. Advancements in Cancer Immunotherapy: Exploring Treatment Options;2024

3. Concomitant Immunotherapy and Metastasis-Directed Radiotherapy in Upper Tract Urothelial Carcinoma: A Biomarker-Driven, Original, Case-Based Proof-of-Concept Study;Journal of Clinical Medicine;2023-12-18

4. Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review;Pharmaceuticals;2023-08-09

5. Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers;Pharmaceutics;2023-07-21